Phase 2 Trial Results: Weight Loss Outcomes in Type 2 Diabetes At the highest 12 mg dose, adults with type 2 diabetes achieved approximately 16.9% mean body weight reduction from baseline at 24 weeks in a randomised, placebo-controlled phase 2 trial published in The Lancet (2023)
Disclaimer: Our medical weight management services are not intended to diagnose, treat, cure, or prevent any disease
Remember: obesity is a chronic disease that often starts early during childhood
The Promises and Pitfalls of BPC-157 BPC-157, or Body Protection Compound-157, is a peptide derived from a protein found in the stomach
Referred to as ileus, the condition occurs when the muscles are unable to move food through the intestines, resulting in a blockage
Laboratory research record on GLP-1S [PMID: 39606869] PubMed laboratory record discussing GLP-1S in a research context